Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.970
-0.170 (-5.41%)
At close: Mar 13, 2026
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 969.84 million as of March 13, 2026. Its market cap has increased by 14.67% in one year.
Market Cap
969.84M
Enterprise Value
387.79M
Revenue
4.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.97
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 969.84M, a decrease of -82.44%. That is a compound annual growth rate of -24.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 969.84M | 23.13% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 1.67B |
| Circio Holding ASA | 1.08B |
| ArcticZymes Technologies ASA | 1.08B |
| Lytix Biopharma AS | 834.37M |
| Zelluna ASA | 457.09M |
| SoftOx Solutions AS | 152.94M |
| EXACT Therapeutics AS | 115.77M |
| Arctic Bioscience AS | 91.65M |